Autoplay
Autocomplete
Previous Lesson
Complete and Continue
The Advanced Women's Health Course
The Advanced Women's Health and HRT Course
Course Disclosure
Presentation Slides
Course Pre-Test
Section 1: Introduction (5:41)
Section 2: Objectives, Steroid Hormone Production, 5 Major Classes of Steroid Hormones, (6:13)
Section 3: DHEA, Optimal DHEAs Serum Levels, Correcting DHEAs levels, DHEA prescriptions (15:01)
Section 4: Pregnenolone/DHEA, How Cholesterol becomes Hormones, Pregnenolone Dosing, Testosterone/DHT, Testosterone in Women (14:48)
Section 5: S/S of Decreased T, Contraindications/Cautions, T Prescribing Tips, Pt Education (27:16)
Section 6: Lab follow-up, Anti-Androgen Treatments, (12:08)
Section 7: FSH, Estrogens, S/S of decreased Estrogens/Menopause, Elevated Estrogens AKA E Dominance (18:04)
Section 8: E can be used for, Contraindications/Cautions w/E, Estrogen Labs – Women Ages 45 & up, E Prescribing Tips (16:47)
Section 9: Various Dosing Plans, E Prescribing Tips (9:57)
Section 10: Progesterone, Low P Levels, P Prescribing Tips, E & P Lab follow-up (18:04)
Section 11: Symptoms should guide HRT, Summary of BHRT, Endometriosis (9:52)
Section 12: PMS/PMDD, Mainstream Treatments, Alternative Treatments, Insulin Triggers Inflammation, Follow-up: Endo/PMS/PMDD (19:36)
Section 13: Cortisol/Adrenal Glands, Fibromyalgia & Chronic Fatigue Syndrome (14:19)
Section 14: Fibromyalgia vs. Hypothyroidism vs. Anemia, FM & CFS are associated with: (18:19)
Section 15: Fibromyalgia & CFS Management, Magnesium Blood Testing, FM & CFS Tx (14:18)
Section 16: Healthy Fats, FM & CFS Management, Cellular use of ferritin & iron (13:59)
Section 17: Iron/Ferritin Lab f/u, Fibromyalgia vs. Hypothyroidism vs. Anemia, Autoimmune Thyroid Problems, Hashimoto’s Hypothyroidism (23:21)
Section 18: Sources of Inflammation, Ingredients that Impact Thyroid, (13:39)
Section 19: Thyroid Hormone Functions, T4, T3, Hashi Treatment Considerations (16:13)
Section 20: Hashimoto’s Hypothyroid Mgmt, Hashi- Liothyronine rx, Deciding How to Rx Thyroid Med, (19:53)
Section 21: Titrating Liothyronine, Using NDT + Lio, Lab Follow-up Hashi (12:26)
Section 22: Summary of Hashi Tx, Chronic/Recurrent UTI/Interstitial Cystitis, Contributory Factors (13:32)
Section 23: Infection Treatments, Interstitial Cystitis/Bladder Pain Syndrome, Mainstream IC Treatments, (6:17)
Section 24: Other IC Tx , Case Study 1 (15:13)
Section 25: Recommendations/Treatments for Case Study 1, Case Study 2, Case Study 3 (14:12)
Section 26: Case Study 4, Case Study 5, Summary of Case Studies (18:55)
Section 27: Practice Integration and Business Considerations (15:25)
Course Post-Test
Audio
Additional Resources, Cheat Sheet, and Informed Consent
Course Evaluation
Course Disclosure
DISCLOSURE ADVANCED WOMENS HRT.docx.pdf
Complete and Continue